- Home
- UAN vs MDXG Comparison
UAN vs MDXG Comparison
Compare UAN & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UAN | MDXG |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | UAN | MDXG |
|---|---|---|
| Price | $94.27 | $6.93 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 75.9K | ★ 777.2K |
| Earning Date | 10-29-2025 | 10-29-2025 |
| Dividend Yield | ★ 7.17% | N/A |
| EPS Growth | ★ 141.96 | N/A |
| EPS | ★ 12.04 | 0.27 |
| Revenue | ★ $614,528,000.00 | $393,442,000.00 |
| Revenue This Year | N/A | $19.13 |
| Revenue Next Year | N/A | $2.11 |
| P/E Ratio | ★ $7.83 | $25.66 |
| Revenue Growth | ★ 16.52 | 14.77 |
| 52 Week Low | $63.45 | $5.79 |
| 52 Week High | $100.89 | $10.14 |
Technical Indicators
Market Signals| Indicator | UAN | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 42.86 | 48.84 |
| Support Level | $94.50 | $6.62 |
| Resistance Level | $97.34 | $6.97 |
| Average True Range (ATR) | 2.43 | 0.26 |
| MACD | -0.53 | -0.01 |
| Stochastic Oscillator | 8.91 | 50.63 |
Price Performance
Historical ComparisonAbout UAN CVR Partners LP Common Units representing Limited Partner Interests
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.